Carmenta Bioscience  
孕产妇和胎儿生物技术公司Carmenta

Carmenta Bioscience, Inc., is a privately held medical technology company dedicated to improving maternal and fetal health. Spun-out of Stanford University School of Medicine in 2012, Carmenta Bioscience is currently developing a highly accurate, serum-based diagnostic test for preeclampsia.

Carmenta Bioscience is a biotechnology company dedicated to addressing unmet medical needs in maternal and fetal health. The co-founders of Carmenta include thoughts leaders in translational medicine from Stanford University and the biopharmaceutical industry.